These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22445102)

  • 21. Synthesis of alpha-galactosyl ceramide (KRN7000) and analogues thereof via a common precursor and their preliminary biological assessment.
    Michieletti M; Bracci A; Compostella F; De Libero G; Mori L; Fallarini S; Lombardi G; Panza L
    J Org Chem; 2008 Nov; 73(22):9192-5. PubMed ID: 18956839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Administration of alpha-galactosylceramide impairs the survival of dendritic cell subpopulations in vivo.
    Simkins HM; Hyde E; Farrand KJ; Ong ML; Degli-Esposti MA; Hermans IF; Ronchese F
    J Leukoc Biol; 2011 May; 89(5):753-62. PubMed ID: 21297009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological activity of ester and ether analogues of alpha-galactosylceramide (KRN7000).
    Shiozaki M; Tashiro T; Koshino H; Nakagawa R; Inoue S; Shigeura T; Watarai H; Taniguchi M; Mori K
    Carbohydr Res; 2010 Aug; 345(12):1663-84. PubMed ID: 20591421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of iNKT Cells Facilitates Liver Repair After Hepatic Ischemia Reperfusion Injury Through Acceleration of Macrophage Polarization.
    Goto T; Ito Y; Satoh M; Nakamoto S; Nishizawa N; Hosono K; Naitoh T; Eshima K; Iwabuchi K; Hiki N; Amano H
    Front Immunol; 2021; 12():754106. PubMed ID: 34691073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Administration of anti-CD25 mAb leads to impaired α-galactosylceramide-mediated induction of IFN-γ production in a murine model.
    Rosalia RA; Štěpánek I; Polláková V; Šímová J; Bieblová J; Indrová M; Moravcová S; Přibylová H; Bontkes HJ; Bubeník J; Sparwasser T; Reiniš M
    Immunobiology; 2013 Jun; 218(6):851-9. PubMed ID: 23182710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant.
    Li X; Fujio M; Imamura M; Wu D; Vasan S; Wong CH; Ho DD; Tsuji M
    Proc Natl Acad Sci U S A; 2010 Jul; 107(29):13010-5. PubMed ID: 20616071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Syntheses of biotinylated alpha-galactosylceramides and their effects on the immune system and CD1 molecules.
    Sakai T; Naidenko OV; Iijima H; Kronenberg M; Koezuka Y
    J Med Chem; 1999 May; 42(10):1836-41. PubMed ID: 10346936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3-fluoro- and 3,3-difluoro-3,4-dideoxy-KRN7000 analogues as new potent immunostimulator agents: total synthesis and biological evaluation in human invariant natural killer T cells and mice.
    Hunault J; Diswall M; Frison JC; Blot V; Rocher J; Marionneau-Lambot S; Oullier T; Douillard JY; Guillarme S; Saluzzo C; Dujardin G; Jacquemin D; Graton J; Le Questel JY; Evain M; Lebreton J; Dubreuil D; Le Pendu J; Pipelier M
    J Med Chem; 2012 Feb; 55(3):1227-41. PubMed ID: 22243602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors.
    Pellicci DG; Patel O; Kjer-Nielsen L; Pang SS; Sullivan LC; Kyparissoudis K; Brooks AG; Reid HH; Gras S; Lucet IS; Koh R; Smyth MJ; Mallevaey T; Matsuda JL; Gapin L; McCluskey J; Godfrey DI; Rossjohn J
    Immunity; 2009 Jul; 31(1):47-59. PubMed ID: 19592275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD1d-dependent immune suppression mediated by regulatory B cells through modulations of iNKT cells.
    Oleinika K; Rosser EC; Matei DE; Nistala K; Bosma A; Drozdov I; Mauri C
    Nat Commun; 2018 Feb; 9(1):684. PubMed ID: 29449556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retinoic acid induction of CD1d expression primes chronic lymphocytic leukemia B cells for killing by CD8
    Ghnewa YG; O'Reilly VP; Vandenberghe E; Browne PV; McElligott AM; Doherty DG
    Clin Immunol; 2017 Oct; 183():91-98. PubMed ID: 28780376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 4,5-cis unsaturated α-GalCer analogues distinctly lead to CD1d-mediated Th1-biased NKT cell responses.
    Cui Y; Li Z; Cheng Z; Xia C; Zhang Y
    Chem Res Toxicol; 2015 Jun; 28(6):1209-15. PubMed ID: 25955524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Negative modulation of invariant natural killer T cell responses to glycolipid antigens by p38 MAP kinase.
    Stuart JK; Bisch SP; Leon-Ponte M; Hayatsu J; Mazzuca DM; Maleki Vareki S; Haeryfar SM
    Int Immunopharmacol; 2010 Sep; 10(9):1068-76. PubMed ID: 20584631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and evaluation of acyl-chain- and galactose-6''-modified analogues of α-GalCer for NKT cell activation.
    Hsieh MH; Hung JT; Liw YW; Lu YJ; Wong CH; Yu AL; Liang PH
    Chembiochem; 2012 Jul; 13(11):1689-97. PubMed ID: 22730199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of Th1-biased cytokine production by alpha-carba-GalCer, a neoglycolipid ligand for NKT cells.
    Tashiro T; Sekine-Kondo E; Shigeura T; Nakagawa R; Inoue S; Omori-Miyake M; Chiba T; Hongo N; Fujii S; Shimizu K; Yoshiga Y; Sumida T; Mori K; Watarai H; Taniguchi M
    Int Immunol; 2010 Apr; 22(4):319-28. PubMed ID: 20181652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of a novel alpha-galactosyl ceramide haptenated-lipid antigen, a useful tool in demonstrating the involvement of iNKT cells in the production of antilipid antibodies.
    Veerapen N; Leadbetter EA; Brenner MB; Cox LR; Besra GS
    Bioconjug Chem; 2010 Apr; 21(4):741-7. PubMed ID: 20345125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of 6"-triazole-substituted α-GalCer analogues as potent iNKT cell stimulating ligands.
    Pauwels N; Aspeslagh S; Elewaut D; Van Calenbergh S
    Bioorg Med Chem; 2012 Dec; 20(24):7149-54. PubMed ID: 23122935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and evaluation of 1,2,3-triazole containing analogues of the immunostimulant alpha-GalCer.
    Lee T; Cho M; Ko SY; Youn HJ; Baek DJ; Cho WJ; Kang CY; Kim S
    J Med Chem; 2007 Feb; 50(3):585-9. PubMed ID: 17266209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Switching invariant natural killer T (iNKT) cell response from anticancerous to anti-inflammatory effect: molecular bases.
    Laurent X; Bertin B; Renault N; Farce A; Speca S; Milhomme O; Millet R; Desreumaux P; Hénon E; Chavatte P
    J Med Chem; 2014 Jul; 57(13):5489-508. PubMed ID: 24428717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Avidity of CD1d-ligand-receptor ternary complex contributes to T-helper 1 (Th1) polarization and anticancer efficacy.
    Wu TN; Lin KH; Chang YJ; Huang JR; Cheng JY; Yu AL; Wong CH
    Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17275-80. PubMed ID: 21987790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.